Previous close | 8.90 |
Open | N/A |
Bid | 8.50 |
Ask | 11.50 |
Strike | 12.50 |
Expiry date | 2024-10-18 |
Day's range | 8.90 - 8.90 |
Contract range | N/A |
Volume | |
Open interest | 5 |
Key Insights BioLife Solutions' estimated fair value is US$24.08 based on 2 Stage Free Cash Flow to Equity BioLife...
Todd Berard, Chief Marketing Officer of BioLife Solutions Inc (NASDAQ:BLFS), executed a sale of 10,000 shares of the company on June 14, 2024.
BioLife's (BLFS) latest product, CryoCase, is compatible with various downstream processing systems, including its own Signata CT-5.